Specialty Directory

Ophthalmology in Plymouth Meeting, PA

Federal CMS data for 17 ophthalmology providers practicing in Plymouth Meeting, PA. Includes Medicare utilization, Open Payments industry funding, and PECOS enrollment status.

17
Providers
Median industry payments
$9,470
17
Ophthalmology Providers
in Plymouth Meeting, PA
$9,470
Median Industry Payments
per provider (2018–2024)
41,725
Median Medicare Services
fee-for-service claims
How to read this directory: Providers are listed by Medicare service volume, which reflects only Medicare fee-for-service patients (typically 65+). This does not represent total practice volume. Industry payments span multiple years and payment types — they are legal and do not indicate wrongdoing. Ophthalmology includes multiple subspecialties with different practice patterns. Learn more →

Ophthalmology Providers

NPPES · Open Payments · Medicare
Provider Medicare Volume Beneficiaries* Top Procedure Industry Payments Payment Type Coverage
KLUFAS, MICHAEL M.D. 69,078 7,175 Eye injection (Vabysmo/faricimab) $336,389 (2018-2024) Consulting (76%) Very High
MEHTA, SONIA MD 54,510 5,104 Eye injection (Vabysmo/faricimab) $26,539 (2018-2024) Consulting (60%) Very High
REGILLO, CARL MD 54,345 6,402 Eye injection (Vabysmo/faricimab) $734,262 (2018-2024) Consulting (80%) Very High
GARG, SUNIR M.D. 51,663 6,021 Eye injection (Vabysmo/faricimab) $203,408 (2018-2024) Consulting (81%) Very High
HSU, JASON MD 49,152 5,623 Eye injection (Vabysmo/faricimab) $3,294 (2018-2024) Consulting (76%) Very High
HO, ALLEN MD 43,815 5,527 Eye injection (Vabysmo/faricimab) $244,278 (2018-2024) Consulting (97%) Very High
CHIANG, ALLEN M.D. 43,473 6,295 Eye injection (Vabysmo/faricimab) $26,861 (2018-2024) Consulting (83%) Very High
GUPTA, OMESH MD 41,818 6,933 Injection, ranibizumab, 0.1 mg $78,140 (2018-2024) Consulting (83%) Very High
SIVALINGAM, ARUNAN M.D. 41,725 6,246 Eye injection (Vabysmo/faricimab) $2,819 (2018-2024) Consulting (84%) Very High
VANDER, JAMES MD 41,116 5,643 Eye injection (Vabysmo/faricimab) $372 (2019-2024) Food & Beverage (100%) Very High
KAISER, RICHARD MD 38,390 5,519 Injection, ranibizumab, 0.1 mg $2,106 (2018-2024) Consulting (95%) Very High
FINEMAN, MITCHELL MD 35,865 7,083 Injection, ranibizumab, 0.1 mg $121 (2023-2024) Food & Beverage (100%) Very High
PARK, CARL M.D. 31,247 5,797 Eye injection (Vabysmo/faricimab) $92 (2024-2024) Food & Beverage (100%) Very High
UHR, JOSHUA M.D. 11,226 1,567 Eye injection (Vabysmo/faricimab) $9,465 (2019-2024) Consulting (68%) Very High
ORLIN, ANTON MD 11,067 3,983 Eye injection (Vabysmo/faricimab) $15,925 (2018-2023) Consulting (91%) Very High
WEBER, AMY M.D. 3,681 3,333 Comprehensive eye exam, established patient $1,326 (2018-2024) Food & Beverage (99%) Very High
DUNN, JAMES M.D. 1,340 823 Retinal imaging (OCT scan) $9,470 (2018-2024) Consulting (67%) Very High
Note: Ophthalmology encompasses multiple subspecialties with different practice patterns. Differences in payment amounts and procedure volumes may reflect subspecialty focus rather than practice quality. Consider viewing individual profiles for full context.

By Practice Pattern

Ophthalmology encompasses multiple practice patterns. Comparing providers within the same pattern provides more meaningful context.

Mixed Practice (16)

ProviderMedicare VolumeIndustry Payments
KLUFAS, MICHAEL 69,078 $336,389
MEHTA, SONIA 54,510 $26,539
REGILLO, CARL 54,345 $734,262
GARG, SUNIR 51,663 $203,408
HSU, JASON 49,152 $3,294
HO, ALLEN 43,815 $244,278
CHIANG, ALLEN 43,473 $26,861
GUPTA, OMESH 41,818 $78,140
SIVALINGAM, ARUNAN 41,725 $2,819
VANDER, JAMES 41,116 $372

Clinical Cardiology (1)

ProviderMedicare VolumeIndustry Payments
WEBER, AMY 3,681 $1,326
Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →